Skip to main content

Mirari Doctor Introduces Revolutionary Cold Plasma Technology for Skin Rejuvenation and Wound Healing

Mirari Doctor, based in Singapore, innovates with the MIRARI® Cold Plasma System, a first-of-its-kind handheld device enhancing patient care through efficacy, cost-effectiveness, and safety.

Mirari Doctor, a leading provider of innovative medical solutions, is proud to announce the launch of its groundbreaking MIRARI® Cold Plasma System. This handheld device, the first of its kind in the world, harnesses the power of cold plasma technology to revolutionize skin rejuvenation and wound healing treatments.

The MIRARI® Cold Plasma System is designed to provide healthcare professionals with a portable, easy-to-use tool that delivers precise and effective treatments. Cold plasma technology has shown immense potential in various medical applications, including dermatology, wound care, and even cancer therapies as alternative medical treatments. Mirari Doctor's device brings this cutting-edge technology to the forefront of patient care, offering efficacy, cost-effectiveness, safety, and an improved patient experience.

"We are thrilled to introduce the MIRARI® Cold Plasma System to the medical community," said CEO of Mirari Doctor. "Our team has worked tirelessly to develop a device that not only improves patient outcomes but also empowers healthcare providers with the latest advancements in medical technology."

The MIRARI® Cold Plasma System has been approved by the Thai FDA and Vietnam MOH for specific uses. While the device is not currently available for sale or use outside of Thailand and Vietnam, Mirari Doctor is committed to expanding its reach to benefit patients worldwide.

In addition to the MIRARI® Cold Plasma System, Mirari Doctor offers a comprehensive range of resources and educational content on various skin conditions, cardiac care, and other health topics. The company's website,, serves as a hub for patients and healthcare professionals to access valuable information on prevention, care, and effective management strategies for a wide array of health concerns.

Mirari Doctor's commitment to innovation extends beyond its products. The company actively engages with the medical community through social media platforms, such as 

to share insights, research, and best practices. By fostering a collaborative environment, Mirari Doctor aims to drive advancements in patient care and improve health outcomes worldwide.

For more information about Mirari Doctor and the MIRARI® Cold Plasma System, please visit or contact the team at

About Mirari Doctor:

Mirari Doctor is a leading provider of innovative medical solutions, dedicated to improving patient care through advanced technology and expert knowledge. With a focus on dermatology, wound care, and cardiac health, Mirari Doctor offers a range of products and resources designed to empower healthcare professionals and enhance patient outcomes. The company's flagship product, the MIRARI® Cold Plasma System, is the world's first handheld cold plasma device for skin rejuvenation and wound healing.


Mirari Doctor 

600 North Bridge Rd #13-01 Parkview Square, Singapore 188788 

Phone: +660885858868 



About the company: MIRARI DOCTOR - MIRARI® Cold Plasma System - The world's first handheld cold plasma device. Efficacy, Cost Effective, Safety, Patient experience

Contact Info:
Name: Mirari Doctor - The secret to cell rejuvenation
Email: Send Email
Organization: Mirari Doctor
Address: 600 North Bridge Rd #13-01 Parkview Square, Singapore 188788
Phone: +660885858868

Video URL:

Release ID: 89124482

Should you identify any discrepancies, concerns, or inaccuracies in the content provided in this press release or require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting Our responsive team is committed to addressing your concerns within 8 hours by taking necessary actions to resolve identified issues diligently or guiding you through the necessary steps for removal. Our dedication lies in providing accurate and reliable information.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.